Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
6
×
Tags
roche
6
×
biotech
life sciences
national blog main
national top stories
boston
boston blog main
boston top stories
deals
fda
clinical trials
genentech
europe top stories
san francisco blog main
san francisco top stories
alexion pharmaceuticals
alnylam pharmaceuticals
atea pharmaceuticals
avapritinib
billy dunn
biogen
biopharma
blueprint medicines
boehringer ingelheim
cancer
cancer immunotherapy
center for medicare and medicaid services
companion diagnostic
coronavirus
covid-19
cstone pharmaceuticals
daniel o'day
dicerna pharamceuticals
drug prices
drug pricing
duchenne
eli lilly
europe blog main
european medicines agency
evrysdi
What
roche
6
×
drug
medicine
fda
approval
billion
currently
deal
gene
intended
medicines
new
oral
pay
pharmaceuticals
recently
swiss
team
therapy
acquire
agreed
announced
antiviral
approved
atea
atrophy
betting
big
biopharma
blueprint
broad
cancer
candidate
caught
causing
confidence
coronavirus
cure
daily
developme
Language
unset
Current search:
roche
×
roche
×
photo
×
@bgr.com
3 years ago
This groundbreaking new coronavirus cure is unlike any other drug we’ve seen so far
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche Puts Up Historic $1.15B for Sarepta Duchenne Gene Therapy Deal
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug
@xconomy.com
5 years ago
In a Genentech Redux, Roche Pays $2.4B for Rest of Foundation Medicine